Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 8,192 | 0 | 0 | 0 | 0 |
| Cost of Goods | 707 | N/A | N/A | N/A | N/A |
| Gross Profit | 7,485 | N/A | N/A | N/A | N/A |
| Operating Expenses | 122,999 | 66,767 | 59,517 | 51,438 | 49,254 |
| Operating Income | -114,807 | -66,767 | -59,517 | -51,438 | -49,254 |
| Other Income | 111,952 | 4,355 | 5,006 | 5,288 | 3,391 |
| Pre-tax Income | -2,855 | -62,412 | -54,511 | -46,150 | -45,863 |
| Income Tax | 1,552 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -4,407 | -62,412 | -54,511 | -46,150 | -45,863 |
| Net Income | $-4,407 | $-62,412 | $-54,511 | $-46,150 | $-45,863 |
| EPS Basic Total Ops | -0.05 | -0.72 | -0.63 | -0.54 | -0.61 |
| EPS Basic Continuous Ops | -0.05 | -0.72 | -0.63 | -0.54 | -0.61 |
| EPS Diluted Total Ops | -0.05 | -0.72 | -0.63 | -0.54 | -0.61 |
| EPS Diluted Continuous Ops | -0.05 | -0.72 | -0.63 | -0.54 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.72 | -0.64 | N/A | N/A |
| EBITDA(a) | $-114,399 | $-66,651 | $-59,414 | $-51,339 | $-49,162 |